Trial intelligence / Profile preview

Neural Mechanisms of Cannabinoid-impaired Decision-Making

NCT03944954Phase 1Completed

Start
Jul 2017
Primary completion
Dec 2023
Countries
1
01

Overview

Phase 1, randomised, double-blind trial. Primary endpoints: Alpha Learning Rate, Self-Report Subjective High and 2 more. Started Jul 2017; status: completed.

Beyond the preview

Go deeper on NCT03944954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03944954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call